Saturday
07.13.2024
6:06 PM
Login form
Search
Calendar
Entries archive

My site

Main » 2022 » February » 28

DARMSTADT, Germany-Thursday 24 February 2022 [ AETOS Wire ]

    New real-world data show MAVENCLAD® (cladribine tablets) had lower annualised relapse rates and longer time to first relapse and time to switch than fingolimod, dimethyl fumarate and teriflunomide in relapsing multiple sclerosis patients
    Additional clinical trial data show patients treated with MAVENCLAD early after a first clinical demyelinating event had a lower occurrence of further relapses or disability progression as compared to placebo

Not intended for UK and U.S. based media

(BUSINESS WIRE) -- Merck, a leading science and technology company, today announced new real-world data from the MSBase Registry demonstrating MAVENCLAD® (cladribine tablets) had more favourable relapse outcomes and longer time to switch to another disease modifying therapy (DMT) compared to the oral DMTs fingolimod, dimethyl fumarate (DMF) and teriflunomide in relapsing ... Read more »

Views: 68 | Added by: africa-live | Date: 02.28.2022

CHICAGO -Friday 11 February 2022 [ AETOS Wire ]

NielsenIQ BASES introduces a new product to help brands stay relevant.
BASES Renovator is a groundbreaking solution that helps brands stay ahead of their competition.

(BUSINESS WIRE)-- Around the globe, more than 230k new products are launched yearly, however, only 8% of consumers are committed to their current brand, according to NielsenIQ’s research. To stay relevant in this constantly evolving competitive environment, brands need to adapt or risk losing market share. However, if brands wait too long to evolve, it may be too late.

NielsenIQ is constantly innovating its product offerings to provide clients with actionable insights that allow them to make efficient, informed decisions. We know that 60% of relaunches do not recover from their downward trend, thus we developed a new, groundbreaking solution that will provide brands comprehensive analytics and faster insights to help them adapt their ex ... Read more »

Views: 58 | Added by: africa-live | Date: 02.28.2022

 • Alchemee’s flagship brand Proactiv® is an iconic product synonymous with acne care

 

ZUG, Switzerland & HAWTHORNE, N.Y.-Wednesday 23 February 2022 [ AETOS Wire ]

(BUSINESS WIRE) -- Galderma and Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro”) announced today they have signed a definitive agreement for Taro to acquire Alchemee, formerly The Proactiv Company (TPC), from Galderma. The agreement between Galderma and Taro includes Alchemee’s business and assets around the world, including the Proactiv® brand.

 

"We are excited to add Proactiv® to Taro’s broad portfolio of prescription and over-the-
counter dermatology products. We look forward to welcoming the Alchemee team into Taro

and working together to continue to make a difference to the millions of people living with
acne around the world.

 

UDAY BALDOTA
CHIEF EXE ... Read more »

Views: 67 | Added by: africa-live | Date: 02.28.2022

KAMPALA, Uganda-Saturday 26 February 2022 [ AETOS Wire ]

(BUSINESS WIRE) -- AIDS Healthcare Foundation (AHF), Africa Bureau today applauded the decision of the Malawi government to remove taxes on sanitary pads. The news of duty and excise tax exemption for sanitary products is a win for organizations and stakeholders, including AHF Malawi, who have championed this advocacy due to the crucial role affordability and accessibility of sanitary pads play in girls’ education and their well-being.

"We commend the government for this bold move. Reducing the cost of sanitary pads will increase access to this important commodity to girls and consequently increase their school attendance and performance. This is a dream come true and an aspiration of every prosperous country," said Triza Hara, Country Program Manager, AHF Malawi. "We look forward to a time when the government will take this a step further and provide free sanitary pads to poor, school-goin ... Read more »

Views: 66 | Added by: africa-live | Date: 02.28.2022 | Comments (0)

PORTLAND, Maine -Tuesday 21 December 2021 [ AETOS Wire ]

    Accelerating into 2022, in accordance with the company’s three-year strategic plan, with a new Northern European leadership team and reset for the company’s German and U.K. businesses
    Continuing to organize the company’s International business around the customer and operate as an increasingly customer-centric organization
    Creating a DACH headquarters in Dusseldorf, Germany to concentrate strengths of Germany, Austria and Switzerland-based teams along with the company’s other Central European locations
    Driving efficiencies to strengthen International commercial capabilities and competitive advantage and accelerating the value creation for all stakeholders

(BUSINESS WIRE)-- Covetrus® (Nasdaq: CVET), a global leader in animal-health technology and services, today announced a new organizational ... Read more »

Views: 81 | Added by: africa-live | Date: 02.28.2022

ZUG, Switzerland-Friday 18 February 2022 [ AETOS Wire ]

(BUSINESS WIRE)-- Galderma, the world’s largest independent dermatology company, announced today that Karen L. Ling will join its Advisory Committee, effective March 1, 2022.

Karen Ling has a tremendous track record in executive roles at AIG, Allergan, Merck and Wyeth, guiding compensation, culture and program strategies that greatly improved shareholder relations and attracted and retained competitive talent. She is an accomplished global human resources executive with more than 25 years of pharmaceutical industry experience.

Ms. Ling recently retired from her role as Executive Vice President and Chief Human Resources Officer of American International Group, Inc. (AIG). In this role, she oversaw all aspects of human capital management, including talent development, talent acquisition, compensation and benefits, and diversity, equity and inclusion. At Allergan, as Executive Vice President and Chief ... Read more »

Views: 71 | Added by: africa-live | Date: 02.28.2022